These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Urgent problems of the treatment and pharmacologic prevention of malaria]. Kotłowski A Wiad Parazytol; 1988; 34(4-6):503-7. PubMed ID: 3071914 [No Abstract] [Full Text] [Related]
4. Chemotherapy of malaria. Talukdar B Indian Pediatr; 1986 May; 23(5):371-5. PubMed ID: 3527970 [No Abstract] [Full Text] [Related]
5. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam. Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808 [TBL] [Abstract][Full Text] [Related]
7. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria. Contacos PG; Coatney GR; Lunn JS; Chin W Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125 [No Abstract] [Full Text] [Related]
8. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP Malar J; 2006 Jul; 5():54. PubMed ID: 16817953 [TBL] [Abstract][Full Text] [Related]
9. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060 [TBL] [Abstract][Full Text] [Related]
10. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?]. Kroeger A Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355 [No Abstract] [Full Text] [Related]
11. Drug resistance in malaria: three cases and a review. Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767 [TBL] [Abstract][Full Text] [Related]
12. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax]. Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948 [TBL] [Abstract][Full Text] [Related]
13. [Ideal treatment of malaria attack: more questions than answers? Experience of a department of infectious diseases]. Muron T; Biron F; Boibieux A; Chi NH; Piens MA; Peyramond D Ann Med Interne (Paris); 1991; 142(4):254-8. PubMed ID: 1929049 [TBL] [Abstract][Full Text] [Related]
14. Hospital and field traials of sulformethoxine with pyrimethamine against Malaysian strains of Plasmodium falciparum and P. vivax. Laing AB Med J Malaya; 1968 Sep; 23(1):5-19. PubMed ID: 4237560 [No Abstract] [Full Text] [Related]